SDHC Q2 2025 Earnings Call Transcript

Delek reported Q2 adjusted EBITDA of $170.2 million, up from $107 million last quarter, and raised its EOP run-rate target to $130 million-$170 million from $80 million-$120 million, indicating stronger-than-expected operational savings and margin capture. DKL adjusted EBITDA was about $120 million, while liquidity improved after an oversubscribed high-yield offering pushed DKL liquidity above $1 billion and supported the revolver payoff. Management also maintained capital returns with $16 million in dividends and $13 million in buybacks, though Q2 still included a $106 million GAAP net loss and Q3 expense guidance rises modestly.

Analysis

DK’s setup is increasingly a self-help story with a midstream embedded call option. The key second-order effect is that DKL liquidity expansion and the completion of Libby 2 reduce the parent’s dependence on refining cash generation, which should compress the market’s “single-cycle refinery” discount and make DK’s equity less pro-cyclical than peers. If that separation keeps progressing, the market may start valuing DK on a sum-of-parts basis rather than on trough refining earnings, which is the real re-rate lever here.

The underappreciated wrinkle is that the EOP uplift appears to be shifting from pure cost cuts toward structural margin capture, which is harder to reverse and therefore more valuable. That means future quarter-over-quarter earnings volatility should decline even if headline crack spreads soften, because a larger share of incremental EBITDA is now company-controlled rather than market-driven. The same dynamic also improves the probability of continued buybacks: once capex normalizes after the first-half-heavy spend, management has more room to recycle cash into repurchases without stressing the standalone balance sheet.

The main risk is that investors over-earn the sustainability of the quarter’s working-capital-supported cash flow and underestimate the 3Q step-up in opex from Libby 2 ramp and higher throughput. In other words, the near-term optics could look less clean even if the medium-term thesis improves, which creates a good setup for volatility around the next print. On SRE, the market may be pricing it as binary upside, but the more important issue is timing: any delay pushes the valuation uplift out by quarters, while a favorable ruling likely benefits more through sentiment and cash-return capacity than through immediate operating economics.

Net-net, this is more attractive as a 6-12 month re-rating trade than as a short-dated earnings trade. The asymmetric outcome is that DK can rerate on improved capital structure and DKL independence even if refining margins merely stay stable; that makes the equity less dependent on the next crack spread move than consensus likely assumes.

Key Decisions for Investors

• Long DK into the next 1-2 quarters as a self-help / sum-of-parts re-rating trade; target a 15-25% upside if DKL separation progress and EOP follow-through remain intact, with risk centered on a weaker 3Q margin print and opex ramp.
• Pair trade: long DK / short an inland refining peer with less visible structural optimization and weaker midstream optionality; thesis is DK’s valuation should decouple as EOP becomes visible in reported EBITDA and DKL liquidity expands.
• Add DKL on weakness over the next 30-60 days if the market overreacts to higher Libby 2-related opex; the risk/reward is favorable because the project is a near-term drag but a medium-term FCF lever.
• For event-driven desks, consider a call spread in DK targeting the next SRE catalyst window; use defined risk because the market may already be partially pricing a favorable outcome, but a positive ruling could be a sharp sentiment catalyst.
• Avoid chasing DK immediately after a strong headline print; wait for post-earnings compression if the market focuses on temporary working-capital or capex noise, since the better entry is likely when volatility normalizes.